TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2013: $19.0K2014: $229.0K2015: $414.0K2016: $2.66M2017: $1.62M2018: $1.61M2019: $6.66M2020: $317.0K2021: $59.0K2022: $114.0K2023: $02024: $33.0K2025: $291.0K$291.0K
2013Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$291.0K+781.8%
2024$33.0K—
2023$0-100.0%
2022$114.0K+93.2%
2021$59.0K-81.4%
2020$317.0K-95.2%
2019$6.66M+314.4%
2018$1.61M-1.0%
2017$1.62M-39.1%
2016$2.66M+543.0%
2015$414.0K+80.8%
2014$229.0K+1105.3%
2013$19.0K—